Diagnóstico e tratamento das síndromes coronarianas agudas sem supradesnível do segmento ST (2022)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- Subjects: CORONARIOPATIA; SÍNDROME CORONARIANA AGUDA; FATORES DE RISCO
- Language: Português
- Imprenta:
- Publisher: Manole
- Publisher place: Santana de Parnaíba [SP]
- Date published: 2022
- Source:
- Título: Tratado de cardiologia socesp
-
ABNT
BARACIOLI, Luciano Moreira et al. Diagnóstico e tratamento das síndromes coronarianas agudas sem supradesnível do segmento ST. Tratado de cardiologia socesp. Tradução . Santana de Parnaíba [SP]: Manole, 2022. . . Acesso em: 28 jan. 2026. -
APA
Baracioli, L. M., Franci, A., Arantes, F. B. B., & Nicolau, J. C. (2022). Diagnóstico e tratamento das síndromes coronarianas agudas sem supradesnível do segmento ST. In Tratado de cardiologia socesp. Santana de Parnaíba [SP]: Manole. -
NLM
Baracioli LM, Franci A, Arantes FBB, Nicolau JC. Diagnóstico e tratamento das síndromes coronarianas agudas sem supradesnível do segmento ST. In: Tratado de cardiologia socesp. Santana de Parnaíba [SP]: Manole; 2022. [citado 2026 jan. 28 ] -
Vancouver
Baracioli LM, Franci A, Arantes FBB, Nicolau JC. Diagnóstico e tratamento das síndromes coronarianas agudas sem supradesnível do segmento ST. In: Tratado de cardiologia socesp. Santana de Parnaíba [SP]: Manole; 2022. [citado 2026 jan. 28 ] - P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes
- Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction
- Doença arterial coronariana aguda
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
- Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor for the prevention of ischemic events in patients with prior myocardial infarction and peripheral artery disease
- Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
